ARCT 8-K 2026-09-23

Arcturus Therapeutics Holdings Inc. (ARCT) 8-K dated 2026-09-23 — accession 0001193805-26-001277. This URL is the filing, not the ARCT hub.

Arcturus Therapeutics Holdings Inc. (ARCT) is a biotechnology company listed on US.

Arcturus Therapeutics Holdings Inc. filed a 8-K on 2026-09-23. Accession 0001193805-26-001277.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ARCT revenue for 2025-12-31 was $82.0M. Net income was -$65.8M. Revenue was down 46.1% from 2024-12-31 to 2025-12-31. ARCT currently screens at market cap $369.4M.

Not investment advice. The ARCT SEC hub lists recent forms. The stock page is the research view.